Fuso Pharmaceutical Industries,Ltd. (JP:4538)
:4538
Total Valuation
Fuso Pharmaceutical Industries,Ltd. has a market cap or net worth of ¥20.62B. The enterprise value is ¥43.04B.
Market Cap¥20.62B
Enterprise Value¥43.04B
Share Statistics
Fuso Pharmaceutical Industries,Ltd. has 9,451,169 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9,451,169
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Fuso Pharmaceutical Industries,Ltd.’s return on equity (ROE) is -0.10 and return on invested capital (ROIC) is 4.78%.
Return on Equity (ROE)-0.10
Return on Assets (ROA)-0.04
Return on Invested Capital (ROIC)4.78%
Return on Capital Employed (ROCE)0.11
Revenue Per Employee44.21M
Profits Per Employee-2.40M
Employee Count1,370
Asset Turnover0.73
Inventory Turnover2.97
Valuation Ratios
The current PE Ratio of Fuso Pharmaceutical Industries,Ltd. is 5.8. Fuso Pharmaceutical Industries,Ltd.’s PEG ratio is 0.02.
PE Ratio5.8
PS Ratio0.34
PB Ratio0.63
Price to Fair Value0.63
Price to FCF-3.84
Price to Operating Cash Flow0.00
PEG Ratio0.02
Income Statement
In the last 12 months, Fuso Pharmaceutical Industries,Ltd. had revenue of 60.56B and earned -3.29B in profits. Earnings per share was -384.90.
Revenue60.56B
Gross Profit16.19B
Operating Income4.13B
Pretax Income-4.97B
Net Income-3.29B
EBITDA5.96B
Earnings Per Share (EPS)-384.90
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Fuso Pharmaceutical Industries,Ltd. pays an annual dividend of ¥45, resulting in a dividend yield of 3.71%
Dividend Per Share¥45
Dividend Yield3.71%
Payout Ratio35.79%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.64
52-Week Price Change16.86%
50-Day Moving Average2.35K
200-Day Moving Average2.18K
Relative Strength Index (RSI)45.00
Average Volume (3m)17.49K
Important Dates
Fuso Pharmaceutical Industries,Ltd. upcoming earnings date is May 12, 2026, TBA (Confirmed).
Last Earnings DateFeb 12, 2026
Next Earnings DateMay 12, 2026
Ex-Dividend Date―
Financial Position
Fuso Pharmaceutical Industries,Ltd. as a current ratio of 1.10, with Debt / Equity ratio of 85.76%
Current Ratio1.10
Quick Ratio0.76
Debt to Market Cap1.02
Net Debt to EBITDA2.52
Interest Coverage Ratio25.66
Taxes
In the past 12 months, Fuso Pharmaceutical Industries,Ltd. has paid -1.68B in taxes.
Income Tax-1.68B
Effective Tax Rate0.34
Enterprise Valuation
Fuso Pharmaceutical Industries,Ltd. EV to EBITDA ratio is 6.02, with an EV/FCF ratio of -6.61.
EV to Sales0.59
EV to EBITDA6.02
EV to Free Cash Flow-6.61
EV to Operating Cash Flow-10.86
Balance Sheet
Fuso Pharmaceutical Industries,Ltd. has ¥3.16B in cash and marketable securities with ¥28.23B in debt, giving a net cash position of -¥25.07B billion.
Cash & Marketable Securities¥3.16B
Total Debt¥28.23B
Net Cash-¥25.07B
Net Cash Per Share-¥2.65K
Tangible Book Value Per Share¥3.69K
Margins
Gross margin is 26.39%, with operating margin of 6.82%, and net profit margin of -5.43%.
Gross Margin26.39%
Operating Margin6.82%
Pretax Margin-8.21%
Net Profit Margin-5.43%
EBITDA Margin9.84%
EBIT Margin6.82%
Analyst Forecast
The average price target for Fuso Pharmaceutical Industries,Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast7.50%
EPS Growth Forecast-281.41%